The markets opened sharply higher with the Dow soaring 106 points to 15,169 as the possibility of military strikes against Syria eased. Nasdaq climbed 18 points to 3724.
On the upside
Five Below (Nasdaq: FIVE) swung to a better than expected profit for the second quarter and lifted its full year guidance.
Oxygen Biotherapeutics (Nasdaq: OXBT) received a patent for “Perfluorocarbons for use in Treating Pruritus.”
SolarCity (Nasdaq: SCTY) signed a multimillion dollar deal with Direct Energy to provide solar electricity to businesses.
On the downside
Neurocrine Biosciences (Nasdaq: NBIX) reported that its tardive dyskinesia treatment NBI-98854 failed a Phase IIb Kinect study.
William Blair lowered its third quarter earnings estimate for Urban Outfitters (Nasdaq: URBN).
BlackBerry (Nasdaq: BBRY) reduced its sales force in the United States.
In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by a margin of nearly 5 to 2 on Nasdaq. The broader S&P 500 climbed 10 points to 1681.
